|
Completed
|
NCT01678937 -
Immune Tolerance and Alloreactivity in Liver Transplant Recipients on Different Monotherapy Immunosuppressive Agents
|
N/A |
|
Completed
|
NCT03781414 -
Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension
|
Phase 2 |
|
Recruiting
|
NCT02260375 -
MSC Therapy in Liver Transplantation
|
Phase 1 |
|
Not yet recruiting
|
NCT04514666 -
VOCs in Kidney and Liver Transplants
|
N/A |
|
Recruiting
|
NCT06400771 -
Safety of DNP007 in Healthy Subjects
|
|
|
Not yet recruiting
|
NCT05335551 -
TRU-IMMUNO: Optimizing Liver Immunosuppression
|
|
|
Completed
|
NCT01745731 -
Cell Infusion Intraportal Autologous Bone Marrow Mononuclear as Enhancer of Liver Regeneration
|
Phase 2 |
|
Enrolling by invitation
|
NCT05082077 -
Global Utilization And Registry Database for Improved preservAtion of doNor Livers
|
|
|
Completed
|
NCT03874286 -
The TOGETHER Project - Liver
|
|
|
Completed
|
NCT04789213 -
Mortality, Morbidity and Risk Factors of Liver Retransplantation
|
|
|
Not yet recruiting
|
NCT05655273 -
Conversion of Maintenance Prograf to Envarsus in Liver Transplant Recipients
|
Phase 4 |
|
Recruiting
|
NCT03603548 -
Comparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus ) in Patients After Liver Transplantation : Single Center Randomised Control Trial
|
N/A |
|
Withdrawn
|
NCT03315052 -
Budesonide for Immunosuppression After Liver Transplantation to Reduce Side Effects
|
Phase 4 |
|
Active, not recruiting
|
NCT05325073 -
Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients
|
Phase 4 |
|
Recruiting
|
NCT05707520 -
Long-term Benefit of MPA in Liver Transplantation
|
|
|
Recruiting
|
NCT04657562 -
The New LC-MS/MS Method for Determination of Unbound Tacrolimus in Plasma
|
|
|
Completed
|
NCT01444079 -
Graft Rejection or Tolerance Affected by Serial Change of Anti-donor Lymphocyte Antibody After Liver Transplantation
|
N/A |
|
Active, not recruiting
|
NCT06153641 -
Cytokeratin 18 Non-invasive Biomarker for Rejection in Liver Transplant Patients
|
|